|
|
|
| home > ebr > summer 2002 > the pivotal role of it systems in drug delivery and innovation |
|
|
 PUBLICATIONS |
European Biopharmaceutical Review
|
| Almost every article about the fate of modern drug discovery or information technology in the life science sector begins by describing the challenges resulting from the enormous data deluge. This article is no exception. The human and mouse genomes have been drafted, the rat genome is awaiting its completion in 2003, high throughput technologies in genomics, screening and chemistry have been established, creating massive amounts of data. There are estimates that even the terabyte scale is already off by an order of magnitude, so when people start talking about petabytes of data, science needs to make sense of it. |
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
C21 Bioventures
22-24 May 2012, Napa, CA
C21 BioVentures™ (C21), annually held in Napa Valley California at the Meritage Resort May 22-24, 2012, is an intimate venue designed for small –privately held enterprises to showcase innovation and to network with potential partners for funding sources. In today’s economic climate, life science companies have found they must make changes or continued existence will be difficult.
More info >> |
|
 |
News and Press Releases |
 |
GE Healthcare Life Sciences completes acquisition of Xcellerex, Inc.
GE Healthcare, the healthcare business of GE (NYSE: GE) announced today that it has completed the acquisition of Xcellerex, Inc., a supplier of innovative manufacturing technologies for the fast-growing biopharmaceutical industry. The acquisition expands GE Healthcare’s offering of technologies and services for the manufacture of biopharmaceuticals such as recombinant proteins, antibodies and vaccines, a key area of growth for the company.The strong strategic fit between the two companies, combined with expanded capabilities in product development and marketing, will offer significant customer benefits through complementary product and service offerings.
More info >> |
|
|
